We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Biovail Settles Canadian Cardizem Suit

Law360 (April 23, 2008, 12:00 AM EDT) -- Pharmaceutical company Biovail Corp. has put another shareholder class action behind it, agreeing to settle with a Canadian pension fund that claimed the company made misleading statements in promoting its hypertension drug Cardizem LA.

Biovail said Wednesday that it had entered into a settlement agreement with the Canadian Commercial Workers Industry Pension Plan under which the fund will be entitled to part of the $138 million settlement reached in a parallel class action last year. Neither the Toronto-based company nor any of the individual defendants named...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.